APA

Cabel L., Riva F., Servois V., Livartowski A., Daniel C., Rampanou A., Lantz O., Romano E., Milder M., Buecher B., Piperno-Neumann S., Bernard V., Baulande S., Bieche I., Pierga J. Y., Proudhon C. & Bidard F. (20180507). Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept study. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Cabel L, Riva F, Servois V, Livartowski A, Daniel C, Rampanou A, Lantz O, Romano E, Milder M, Buecher B, Piperno-Neumann S, Bernard V, Baulande S, Bieche I, Pierga J Y, Proudhon C and Bidard F-C. 20180507. Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept study. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Cabel L., Riva F., Servois V., Livartowski A., Daniel C., Rampanou A., Lantz O., Romano E., Milder M., Buecher B., Piperno-Neumann S., Bernard V., Baulande S., Bieche I., Pierga J. Y., Proudhon C. and Bidard F. (20180507). Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept study. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Cabel L, Riva F, Servois V, Livartowski A, Daniel C, Rampanou A, Lantz O, Romano E, Milder M, Buecher B, Piperno-Neumann S, Bernard V, Baulande S, Bieche I, Pierga J Y, Proudhon C and Bidard F-C. Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept study. : Annals of oncology : official journal of the European Society for Medical Oncology. 20180507.